P16 Serum calprotectin levels in patients with systemic lupus erythematosus and association with disease activity – Single centre study
Main Authors: | Daniela Marasović Krstulović, Karla Vrkić, Jasenka Oreb, Marin Petrić, Luka Milovac, Dijana Perković |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
The Levels of Serum Serotonin Can Be Related to Skin and Pulmonary Manifestations of Systemic Sclerosis
by: Marin Petrić, et al.
Published: (2022-01-01) -
Case of Acute Disseminated Encephalomyelitis Associated with Cytomegalovirus Reactivation in an Immunocompromised Systemic Lupus Erythematosus Patient
by: Mirela Pavicic Ivelja, et al.
Published: (2021-08-01) -
Prescription Trends of Biologic DMARDs in Treating Rheumatologic Diseases: Changes of Medication Availability in COVID-19
by: Mislav Radić, et al.
Published: (2023-07-01) -
Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?
by: Marin Petrić, et al.
Published: (2023-05-01) -
Serum pentosidine levels in systemic lupus erythematosus
by: Renato Nisihara, et al.
Published: (2021-01-01)